Colon polyps and cancer

Endoscopy

Volumn 36, Issue 1, 2004, Pages 3-7

  Kronborg, Ole ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BIOLOGICAL MARKER; CYCLINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FOLIC ACID; IMMUNOSUPPRESSIVE AGENT; KI 67 ANTIGEN; MESSENGER RNA; METHIONINE; NONSTEROID ANTIINFLAMMATORY AGENT; ORNITHINE DECARBOXYLASE; PROTEIN MLH1; PROTEIN MSH2; PROTEIN P53; TELOMERASE;

ARGON PLASMA COAGULATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CLINICAL TRIAL; COLON ADENOMA; COLON CANCER; COLON OBSTRUCTION; COLON POLYP; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DNA DETERMINATION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENDOSCOPY; FECES; FIBER; FOOD INTAKE; HUMAN; LONG TERM CARE; MASS SCREENING; MORTALITY; OCCULT BLOOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM CANCER; REVIEW; STENT;

CLINICAL TRIALS; COLONIC NEOPLASMS; COLONIC POLYPS; HUMANS; MASS SCREENING; OCCULT BLOOD; SIGMOIDOSCOPY;

EID: 0346055151     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-814120     Document Type: Review

References (49)

1. Scholefield JH, Moss S, Sufi F et al. Effect of faecal occult blood screening on mortality from colorectal cancer: Results from a randomised controlled trial. Gut 2002; 50: 840-844
2. Little J, Owen RW, Fernandez F et al. Asymptomatic colorectal neoplasia and fecal characteristics: A case-control study of subjects participating in the Nottingham Fecal Occult Blood Screening Trial. Dis Colon Rectum 2002; 45: 1233-1241
3. Starkey BJ. Screening for colorectal cancer. Ann Clin Biochem 2002; 39: 351-365
4. Young GP, St. John JB, Winawer SJ et al. Choice of fecal occult blood tests for colorectal cancer screening: Recommendations based on performance characteristics in population studies. A WHO and OMED Report. Am J Gastroenterol 2002; 97: 2499-2507
5. Zhang B, Nakama H, Fattah ASMA et al. Lower specificity of occult-blood test on stool collected by digital rectal examination. Hepatogastroenterology 2002; 49: 165-167
6. Fludger S, Turner AM, Harvey RF et al. Controlled prospective study of faecal occult blood screening for colorectal cancer in Bury, black pudding capital of the world. BMJ 2002; 325: 1444-1445
7. Rasmussen M, Fenger C, Kronborg O. Diagnostic yield in a biennial Hemoccult-II screening program compared to a once-only screening with flexible sigmoidoscopy and Hemoccult-II. Scand J Gastroenterol 2003; 38: 114-118
8. Segnan N, Senore C, Andreoni B et al. Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy" - SCORE. J Natl Cancer Inst 2002; 94: 1763-1772
9. Blom J, Lidén A, Jeppsson B et al. Compliance and findings in a Swedish population screened for colorectal cancer with sigmoidoscopy. Eur J Surg Oncol 2002; 28: 827-831
10. Santavirta J. Screening sigmoidoscopy in persons aged 60 years. Colorectal Dis 2002; 4: 184-188
11. Larsen IK, Grotmol T, Bretthauer M et al. Continuous evaluation of patient satisfaction in endoscopy centres. Scand J Gastroenterol 2002; 37: 850-855
12. Bretthauer M, Hoff G, Thiis-Evensen E et al. Use of a disposable sheath system for flexible sigmoidoscopy in decentralized colorectal cancer screening. Endoscopy 2002; 34: 814-818
13. Levin TR, Conell C, Shapiro JA et al. Complications of screening flexible sigmoidoscopy. Gastroenterology 2002; 123: 1786-1792
14. Cappel WH, De Vos Tot Nederveen, Nagengast FM, Griffioen GG et al. Surveillance for hereditary nonpolyposis colorectal cancer: A long-term study on 114 families. Dis Colon Rectum 2002; 45: 1588-1594
15. Zubarik R, Ganguly E, Benway D et al. Procedure-related abdominal discomfort in patients undergoing colorectal cancer screening: A comparison of colonoscopy and flexible sigmoidoscopy. Am J Gastroenterol 2002; 97: 3056-3061
16. Cucino C, Buchner AM, Sonnenberg A. Continued rightward shift of colorectal cancer. Dis Colon Rectum 2002; 45: 1035-1040
17. Mensink PBF, Kolkman JJ, Van Baarlen J et al. Change in anatomic distribution and incidence of colorectal carcinoma over a period of 15 years: Clinical considerations. Dis Colon Rectum 2002; 45: 1393-1396
18. Nelson DB, McQuaid KR, Bond JH et al. Procedural success and complications of large-scale screening colonoscopy. Gastrointest Endosc 2002; 55: 307-314
19. Imperiale TF, Wagner DR, Lin CY et al. Results of screening colonoscopy among persons 40 to 49 years of age. N Engl J Med 2002; 346: 1781-1785
20. Pignone M, Rich M, Teutsch SM et al. Screening for colorectal cancer in adults at average risk: A summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 137: 132-141
21. Ko CW, Kreuter W, Baldwin LM. Effect of Medicare coverage on use of invasive colorectal cancer screening tests. Arch Intern Med 2002; 162: 2581-2586
22. Frattini M, Balestra D, Pilotti S et al. Tumor location and detection of k-ras mutations in stool from colorectal cancer patients. J Natl Cancer Inst 2003; 95: 72-73
23. Kiran PR, Glass RE. Duration of symptoms and spread of colorectal cancer: A short history does not mean early disease. Ann R Coll Surg Engl 2002; 84: 381-385
24. Fernandez E, Porta M, Malats N et al. Symptom-to-diagnosis interval and survival in cancers of the digestive tract. Dig Dis Sci 2002; 47: 2434-2440
25. Selvachandran SN, Hodder RJ, Ballal MS et al. Prediction of colorectal cancer by a patient consultation questionnaire and scoring system: A prospective study. Lancet 2002; 360: 278-283
26. Eckardt VF, Schmitt T, Kanzler G et al. Does scant hematochezia necessitate the performance of total colonoscopy? Endoscopy 2002; 34: 599-603
27. Arumugam PJ, Joseph A, Sweerts M et al. Severe dysplastic lesions in the colon: How aggressive should we be? Colorectal Disease 2002; 4: 345-347
28. Burton S, Eddy B, Li WY. Reliability of preoperative biopsies in the histological grading of colorectal adenocarcinomas. Ann R Coll Surg Engl 2003; 85: 23-25
29. Keller R, Winde G, Terpe HJ et al. Fluorescence endoscopy using a fluorescein-labeled monoclonal antibody against carcinoembryonic antigen in patients with colorectal carcinoma and adenoma. Endoscopy 2002; 34: 801-807
30. Baron JA, Cole BF, Sandler RS et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003; 348: 891-899
31. Sandler RS, Halabi S, Baron JA et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 2003; 348: 883-890
32. Voskuil DW, Kampman E, Grubben MJAL et al. Meat consumption and meat preparation in relation to colorectal adenomas among sporadic and HNPCC family patients in the Netherlands. Eur J Cancer 2002; 38: 2300-2308
33. Chappel KS, Scott N, Path MRC et al. Analysis of cyclooxygenase expression in human colorectal adenomas. Dis Colon Rectum 2002; 45: 1316-1324
34. Flood A, Caprario L, Chaterjee N et al. Folate, methionine, alcohol, and colorectal cancer in a prospective study of women in the United States. Cancer Causes Control 2002; 13: 551-561
35. Peters U, Sinha R, Chatterjee N et al. Dietary fiber and colorectal adenoma in a colorectal cancer early detection programme. Lancet 2003; 361: 1491-1495
36. Bingham SA, Day NE, Luben R et al. Dietary fiber in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): An observational study. Lancet 2003; 361: 1496-1501
37. Torlakovic E, Skovlund E, Snover DC et al. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 2003; 27: 65-81
38. Kanamaru T, Tanaka KI, Kotani J et al. Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer. Int J Mol Med 2002; 10: 205-210
39. Freitas D, Goulão MH, Camacho E et al. Clinical relevance of proliferation biomarkers and P53 expression in rectal mucosa and sporadic colonic adenomas: A prospective study. Hepatogastroenterology 2002; 49: 1269-1274
40. Nusko G, Mansmann U, Kirschner T et al. Risk related surveillance following colorectal polypectomy. Gut 2002; 51: 424-428
41. Atkin WS, Saunders BP. Surveillance guidelines after removal of colorectal adenomatous polyps. British Society for Gastroenterology, Association of Coloproctology for Great Britain and Ireland. Gut 2002; 51 (Suppl 5): 6-9
42. Kronborg O. Screening for colorectal cancer. Scand J Surg 2003; 92: 20-24
43. Konishi K, Kaneko K, Kurahashi T et al. A comparison of magnifying and nonmagnifying colonoscopy for diagnosis of colorectal polyps: A prospective study. Gastrointest Endosc 2003; 57: 48-53
44. Parikshak M, Pawlak SE, Eggenberger JC et al. The role of endoscopic colon surveillance in the transplant population. Dis Colon Rectum 2002; 45: 1655-1660
45. Regula J, Wronska E, Polkowski M et al. Argon plasma coagulation after piecemeal polypectomy of sessile colorectal adenomas: Long-term follow up study. Endoscopy 2003; 35: 212-218
46. Brooker JC, Saunders BP, Shah SG et al. Treatment with argon plasma coagulation reduces recurrence after piecemeal resection of large sessile colonic polyps: A randomized trial and recommendations. Gastrointest Endosc 2002; 55: 371-375
47. Dorudi S, Steele RJC, McArdle CS. Surgery for colorectal cancer. Br Med Bull 2002; 64: 101-118
48. Keymling M. Colorectal stenting. Endoscopy 2003; 35: 234-238
49. Brenner H. Long-term survival rates of cancer patients achieved by the end of the 20th century: A period of analysis. Lancet 2002; 360: 1131-1135